Entero Therapeutics CSO Jack Syage resigns; salary cut to $66,560 as cost reduction

GridAI Technologies Corp.

Dr. Jack Syage resigned as Chief Scientific Officer effective July 17, 2024, will remain President and Board member.
Resignation is part of cost reduction measures, not due to any disagreement with company policies.
Annual base salary reduced to $66,560, effective July 1, 2024; other compensation terms unchanged.
CEO James Sapirstein signed the filing on July 23, 2024.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jack Syage

Chief Scientific Officer

GRDX · GridAI Technologies Corp.

Effective: 2024-07-17
Filed: July 23, 2024, 7:59 PM ET

Dr. Jack Syage, the Company’s Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jack Syage resigned as Chief Scientific Officer at GridAI Technologies Corp..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

Dr. Jack Syage, the Company’s Chief Scientific Officer, President and member of the Board, whereby he tendered his resignation from the role of Chief Scientific Officer of the Company, effective immediately.

View on SEC.gov

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-24-081888

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.